期刊文献+

DNA甲基转移酶3A基因突变阳性的T淋巴母细胞淋巴瘤/白血病一例临床分析

Clinical analysis of DNMT3A mutated T-lymphoblastic leukemia / lymphoma: one case report
原文传递
导出
摘要 目的分析DNA甲基转移酶3A(DNMT3A)基因突变阳性的T淋巴母细胞淋巴瘤/白血病(T-LBL/ALL)的临床及预后特征。方法报道1例DNMT3A基因突变阳性的T—LBL/ALL的发生、发展及对治疗的反应并复习相关文献。结果DNMT3A基因突变可出现在T—LBL/ALL患者中,该患者具有病程长、白细胞计数不高、伴纵隔病变和肝脾大等特征,且对治疗的反应较差。结论DNMT3A基因突变可能是T-LBL/ALL患者预后不良的一个指标。
出处 《白血病.淋巴瘤》 CAS 2016年第4期241-243,共3页 Journal of Leukemia & Lymphoma
基金 湖南省医药卫生科研计划(2013SK3259)
  • 相关文献

参考文献1

二级参考文献26

  • 1王吉耀.内科学[M].2版.北京:人民卫生出版社,2012:273.
  • 2Dohner K, Dohner H. Molecular characterization of acute my?eloid leukemiaJ J]. Haematologica, 2008, 93(7):976-982.
  • 3Nimer SD. Is it important to decipher the heterogeneity of "nor?mal karyotype AML"?[J]. Best Pract Res Clin Haematol, 2008, 21 (I ):43-52.
  • 4PatelJP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia[J]. N EnglJ Med, 2012, 366( 12):1079-1089.
  • 5Abdel- Wahab 0, Mullally A, Hedvat C, et al. Genetic characterization of TETl, TET2, and TET3 alterations in myeloid malignanciesJ J], Blood, 2009, 114( I ):144-147.
  • 6Ley TJ, Ding L, Walter MJ, et al. DNMT3a mutations in acute myeloid leukemialJ], N EnglJ Med, 2010, 363(25):2424-2433.
  • 7Sargent DJ, Hayes DF. Assessing the measure of a new drug: is survival the only thing that matters?[J].J Clin Oncol, 2008, 26 (12):1922-1923.
  • 8Jurkowska RZ,Jurkowski TP,Jeltsch A. Structure and function of mammalian DNA methyltransferases[J]. Chembiochem, 2011,12(2):206-222.
  • 9Jones PA, Baylin SB. The epigenomics of cancerJ J], Cell, 2007, 128 (4) :683-692.
  • 10Hopfer 0, Komor M, Koehler IS, et al. Aberrant promotor meth?ylation in MDS hematopoietic cells during in vitro lineage spe?cific differentiation is differently associated with DNMT iso?formsJ J]. Leuk Res, 2009, 33(3):434-442.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部